Huang Chuan-Fu, Tsai Zon-Po, Li Cho-Shin, Wang Kao-Lun, Wang Yeou-Chih
Division of Neurosurgery, Chung Shan Medical University Hospital, Taichung, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 2002 Jun;65(6):241-6.
Patients with hypertensive intracerebral hemorrhage (ICH) are at risk for delayed neurological deterioration, especially during the second week after onset. Mass effect due to vasogenic edema caused by ICH has been shown to cause later deterioration. Control of brain edema and increased intracranial pressure (ICP) are related events that determine outcome. In this study, we compared the effects of three different treatments on brain edema caused by ICH.
Thirty-nine patients with ICH were involved in this study. Of these patients, 11 had medical therapy (group A), 15 were treated with stereotactic aspiration plus local administration of urokinase (group B), and 13 underwent conventional craniotomy and hematoma removal (group C). The intracerebral hematoma volume on admission was measured on the the brain computed tomographs (CTs), and the cerebral edema volumes surrounding the hematoma were assessed with CT scans every 5 to 7 days after symptom onset.
The median intracerebral hematoma volumes were 23, 50 and 51 ml in groups A, B and C, respectively. Peak edema volume surrounding the hematoma was observed 5 to 15 days after symptom onset. A significant correlation (p < 0.05) was noted between peak edema and hematoma volumes in all groups. The ratio of median peak edema volume to median hematoma volume was 3.280 in group A, which was significantly higher than those in group B (0.745) and group C (0.863) (p < 0.05).
The study revealed that brain edema induced by hypertensive ICH could be significantly ameliorated by surgical management. Stereotactic aspiration with local administration of urokinase was as effective as conventional craniotomy in reduction of brain edema volume caused by ICH and was characterized by its minimal invasiveness, easy performance, and safety.
高血压性脑出血(ICH)患者有延迟神经功能恶化的风险,尤其是在发病后的第二周。ICH引起的血管源性水肿导致的占位效应已被证明会导致后期恶化。控制脑水肿和颅内压升高是决定预后的相关因素。在本研究中,我们比较了三种不同治疗方法对ICH所致脑水肿的影响。
39例ICH患者参与了本研究。其中,11例接受药物治疗(A组),15例接受立体定向抽吸加局部应用尿激酶治疗(B组),13例接受传统开颅血肿清除术(C组)。入院时通过脑部计算机断层扫描(CT)测量脑内血肿体积,并在症状发作后每5至7天通过CT扫描评估血肿周围的脑水肿体积。
A、B、C组脑内血肿体积中位数分别为23、50和51ml。症状发作后5至15天观察到血肿周围的水肿体积峰值。所有组的水肿峰值与血肿体积之间均存在显著相关性(p<0.05)。A组中位数峰值水肿体积与中位数血肿体积之比为3.280,显著高于B组(0.745)和C组(0.863)(p<0.05)。
该研究表明,手术治疗可显著改善高血压性ICH所致的脑水肿。立体定向抽吸加局部应用尿激酶在减少ICH所致脑水肿体积方面与传统开颅术效果相同,且具有微创、操作简便和安全的特点。